Leg Cramps Ointment
NDC Package 54973-3202-2
Package Information
Leg Cramps (aconitum napellus, arnica montana, ledum palustre twig, magnesium phosphate, dibasic trihydrate, toxicodendron pubescens leaf, and viscum album fruiting top) ointment is apply liberally to affected area. This formulation utilizes a ointment delivery system. Marketed by Hyland's Inc., this product is identified by NDC 54973-3202.
Identification & Billing
Clinical Specifications
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 54973 - Hyland's Inc.
- 54973-3202 - Leg Cramps
- 54973-3202-2 - 10 g in 1 TUBE
- 54973-3202 - Leg Cramps
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54973-3202). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54973-3202-2 identifies a specific commercial package of 10 g in 1 tube of Leg Cramps, a human over the counter drug labeled by Hyland's Inc.. This ointment is formulated for topical use and contains aconitum napellus; arnica montana; ledum palustre twig; magnesium phosphate, dibasic trihydrate; toxicodendron pubescens leaf; viscum album fruiting top as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hyland's Inc. on May 12, 2015. The current certification is valid through December 31, 2026.
How is this Hyland's Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54973320202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.